Article ; Online: Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter.
2024 Volume 329, Page(s) 121780
Abstract: Our research aimed to enhance the oral bioavailability of doxorubicin hydrochloride (DOX·HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we developed a new method that utilizes a coating material to encapsulate the drug ...
Abstract | Our research aimed to enhance the oral bioavailability of doxorubicin hydrochloride (DOX·HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we developed a new method that utilizes a coating material to encapsulate the drug in liposomes, which can specifically target intestinal taurine transporter proteins. This coating material, TAU-CS, was created by combining taurine with chitosan. We characterized TAU-CS using various methods, including |
---|---|
MeSH term(s) | Chitosan/chemistry ; Doxorubicin/chemistry ; Doxorubicin/pharmacology ; Drug Carriers/chemistry ; Liposomes/chemistry ; Particle Size ; Spectroscopy, Fourier Transform Infrared ; Taurine/drug effects ; Taurine/metabolism |
Chemical Substances | Chitosan (9012-76-4) ; Doxorubicin (80168379AG) ; Drug Carriers ; Liposomes ; Taurine (1EQV5MLY3D) ; taurine transporter (148686-53-7) |
Language | English |
Publishing date | 2024-01-06 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 1501516-6 |
ISSN | 1879-1344 ; 0144-8617 |
ISSN (online) | 1879-1344 |
ISSN | 0144-8617 |
DOI | 10.1016/j.carbpol.2024.121780 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.